Brain tumour cells found circulating in blood

Credit: Faculty of Medicine NTNU

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

Researchers from the University Medical Center Hamburg-Eppendorf, in Hamburg, found that patients with an aggressive form of tumour known as sometimes have tumour cells circulating in their blood.

The discovery could help doctors improve the way they monitor how the disease progresses, and could have implications for treatment.

Until recently it was believed that glioblastoma is restricted to the brain, as few patients with the disease develop secondary tumours in other parts of the body.

The reason for this lack of spread is unclear, with some experts suggesting that brain cancer cells are unable to pass through the barrier that separates circulating blood from the brain's fluids, known as the blood brain barrier.

But others believe that it could simply be that these particular brain tumour cells are unable to grow in other organs, or that they do not have time to grow before the fatal effects of the primary tumour take hold.

The new study, led by Carolin Müller and published in the journal Science Translational Medicine, looked at from 141 patients with glioblastoma and found that one in five (20.6 per cent) contained circulating tumour cells.

Dr Steve Pollard, a Cancer Research UK glioblastoma expert, who was not involved in the research, commented on the surprisingly high number of patients in which circulating cells were found.

"Fishing for rogue tumour cells in blood samples is an exciting area of research and this new study shows that circulating tumour cells can be found in more people with glioblastoma than previously thought," he said.

In a related article commenting on the new study, Lara Perryman and Dr Janine Erler suggest that the findings could have an impact on the diagnosis and treatment of glioblastoma patients in the future.

And while Cancer Research UK's Dr Pollard agrees, he cautioned that a greater understanding of these errant brain will be needed as glioblastoma is highly genetically diverse.

"This could be helpful in diagnosing the disease, although given how diverse the different cells within a patient can be, research will be needed to work out how these circulating cells relate to the primary cancer," he said.

The German team believe their findings may also explain why some transplant recipients who receive organs from brain tumour have gone on to develop cancer.

This may be critical, says Dr Pollard, as new ways of treating glioblastoma are developed.

"This will be important when new therapies emerge, as improvements in survival rates may offer more time for these rogue to spread around the body and establish new tumours, something that's evident in rare cases of developing following organ donation."

More information: Muller, C, et al. (2014). "Hematogenous dissemination of glioblastoma multiforme." Science Translational Medicine, 6 (247), 247-247 DOI: 10.1126/scitranslmed.3009095

Perryman, L., & Erler, J. (2014). "Brain Cancer Spreads." Science Translational Medicine, 6 (247), 247-247 DOI: 10.1126/scitranslmed.3009920

add to favorites email to friend print save as pdf

Related Stories

Immune system to fight brain tumors

May 30, 2013

Research at Lund University in Sweden gives hope that one of the most serious types of brain tumour, glioblastoma multiforme, could be fought by the patients' own immune system. The tumours are difficult to remove with surgery ...

'Liquid biopsy' offers new way to track lung cancer

Jun 03, 2014

(Medical Xpress)—Scientists have shown how a lung cancer patient's blood sample could be used to monitor and predict their response to treatment – paving the way for personalised medicine for the disease.

Recommended for you

Video: Is that double mastectomy really necessary?

11 hours ago

When Angeline Vuong, 27,was diagnosed with cancer in one breast earlier this year, her first reaction was "A DOUBLE MASTECTOMY. NOW. " Turns out, she's far from alone: a recent JAMA study of 190,000 breast cancer cases in ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Egleton
not rated yet Aug 01, 2014
Dr seyfreid argues that cancer is a metabolic disease.
http://www.bc.edu...ied.html
The genes from a cancerous cell can be transplanted into a stem cell and the stem cell will go on to produce a healthy oraganism.
Gene damage is an epi-phenomenon.
Genes do not control the cell, they are RNA templates for protein folding. The environment controls the cells' behaviour.